MEDIA RELEASE 4 July 2020 WHO today accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine and lopinavir/ritonavir arms. The Solidarity Trial was established by WHO to find an effective COVID-19 treatment for hospitalized…
OPINION By Dr Abdul Malik Mohamed Thalha, Dr Yeong Yeh Lee, Dr Alwi Besari & Dr Sharifah Faridah Syed Omar We are at the most unprecedented of times. The COVID-19 pandemic has been gaining momentum since the first report came…
A research team at Oxford University has recently found a cheap and widely available drug called dexamethasone that can be used to effectively treat severe forms of COVID-19. The 'breakthrough' drug has shown to significantly reduce the number of deaths among those seriously ill with…
While bats have been put forward as the original host of SARS-CoV-2 nonetheless, the transmission of the virus from bats to humans requires intermediate hosts as well. Several studies have linked pangolins with SARS-CoV-2 infection where coronaviruses found in pangolin are highly similar to the novel coronavirus, which suggests that the mammal is the most likely intermediate host. Prof Dr Abdul Rahman Omar, Dean Faculty of Veterinary Medicine, Universiti Putra Malaysia, however, warns that further study needs to be carried out to identify additional intermediate hosts.
The Malaysian Health Coalition (MHC) understands and supports the government’s decision to transition into the recovery phase of the movement control order (RMCO). The gradual reopening of public life in Malaysia must rely on appropriate guidance from all areas of government and the Ministry of Health. We must remain vigilant until a vaccine for Covid-19 is available.
A group of academics from the Faculty of Medicine, University of Malaya have developed a guideline for Return to Work after the Movement Control Order (MCO) for COVID-19 infection. The guide covers commonly asked questions such as the need to test employees returning to work after the Movement Control Order (MCO) for COVID-19 infection, available testing methods and how to protect employees and avoid a COVID-19 outbreak at the workplace including the use of technology.
This week the Ministry of Education Malaysia (MOE) released a guideline and standard operating procedure (SOP) regarding school management and measures to control the spread of COVID-19. The guidelines have been endorsed by the Ministry of Health Malaysia (MOH) and the National Security Council (MKN). This guideline covers all schools under MOE as well as the private educational institutions registered with MOE.
Prime Minister Tan Sri Muhyiddin Yassin today announced that the country’s Movement Control Order (MCO) which ends on June 9, will be replaced with the Recovery Movement Control Order (RMCO) starting from June 10 until August 31 with more relaxed conditions. This includes allowing for domestic tourism and interstate travel, except for areas placed under Enhanced MCO (EMCO). Almost all social, religious, business and educational activities are also allowed to resume in stages under strict SOPs during the RMCO. We asked experts to comment on this latest development.
The world is celebrating the World Environment Day for the 46th time. While this day aims to remind ourselves on the importance of environmental protection, we should reflect on how successful we have been in doing so in the last half a decade. The COVID-19 virus, which has infected over 6 million people and has taken more than 300,000 lives to date, certainly gives an alarming signal that humans should put more effort in protecting the environment.
The full extent of COVID-19’s impact on our health system and people with NCDs remains to be seen. However, there is clear evidence of its disruption to other areas of healthcare as well as its disproportionately harmful effects on people with NCDs. The 2019 NHMS report is a wake-up call for Malaysians to take urgent action for our own future health. As such, the government must refocus our health system and develop health policies to address both COVID-19 and NCD care in the immediate future.